Alpen Group was founded in Switzerland with a singular focus: to operate at the highest end of regulated cannabis manufacturing.
Based in one of the world’s most demanding regulatory environments, we work within a niche segment of the cannabis market that values precision, compliance and long-term credibility. Our work spans product development, manufacturing, and controlled supply within tightly governed frameworks, where quality systems, process discipline, and consistency are non-negotiable.
As cultivation and manufacturing capacity as well as regulatory pathways continue to evolve, Alpen Group is building a platform designed for longevity — one that can support growth without compromising standards. We focus on doing fewer things, exceptionally well, and laying the groundwork for what regulated cannabis in Europe is becoming.

Switzerland attracts more multinational headquarters than any other country in the world. The global consumer trust for “Swiss-made” brands and products creates a well-deserved reputation for quality, precision, integrity, health, and sustainability. Alpen Group builds upon these proud Swiss concepts, bringing them full-circle in the global cannabis industry.
Alpen Group features sophisticated branded products and infrastructure unparalleled in Europe. Imbued with Swiss excellence and global experience, we strive to deliver the best cannabis experiences across the globe. As Europe’s cannabis landscape grows into full legalization, Alpen Group stands as a leading European global player.
Alpen Group is led by a multidisciplinary team with experience spanning pharmaceuticals, life sciences, regulated cannabis, manufacturing and private equity.
Our leadership combines scientific, operational, and investment expertise developed in highly regulated environments, enabling us to build compliant and scalable platforms.